First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Position Boosted by NBC Securities Inc.

NBC Securities Inc. grew its position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 21,400.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,075 shares of the company’s stock after buying an additional 1,070 shares during the quarter. NBC Securities Inc. owned approximately 0.20% of First Trust Nasdaq Pharmaceuticals ETF worth $29,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in FTXH. Vivaldi Capital Management LP boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 15.6% in the fourth quarter. Vivaldi Capital Management LP now owns 8,677 shares of the company’s stock worth $243,000 after buying an additional 1,171 shares during the period. Summit Investment Advisors Inc. boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 13.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 14,173 shares of the company’s stock worth $382,000 after buying an additional 1,633 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 17.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock worth $442,000 after buying an additional 2,384 shares during the period. Finally, LPL Financial LLC boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 9.3% in the fourth quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock worth $1,507,000 after buying an additional 4,776 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

Shares of FTXH opened at $26.10 on Friday. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $23.29 and a one year high of $29.72. The company has a 50-day moving average of $25.13 and a two-hundred day moving average of $26.69. The stock has a market cap of $14.36 million, a price-to-earnings ratio of 16.72 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Thursday, March 27th were issued a $0.0992 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.52%. The ex-dividend date of this dividend was Thursday, March 27th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.